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has been described, 3 prompt and effective surgical and 
drug therapy is essential. 
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Myasthenia gravis complicated by sarcoidosis 
Iwao Takanami, MD, ~ Tctsuo Imamura,  MD, b and 
Susumu Kodaira, MD, a Tokyo, Japan 
Myasthenia gravis (MG) complicated by sarcoidosis i
rare. Whether this complication represents he association 
between the two diseases or a simple coincidence is 
unclear. We encountered a patient in whom MG seemed 
to have induced sarcoidosis. 
A 32-year-old woman visited our department because 
of blepharoptosis n February 1990. The blepharoptosis 
was improved by the tension test. X-ray examination and 
computed tomographic scanning of the chest showed no 
abnormalities. Results of the serum acetyleholine r ceptor 
antibody test were positive. Electromyography showed the 
typical waning phenomenon after continuous peripheral 
nerve stimulation. On the basis of these findings, a 
diagnosis of MG was made. She was followed up without 
administration of anticholinesterase drugs. 
In November 1992, she noticed fatigability of the skel- 
etal muscles, difficulty in speech and swallowing, and 
frequent choking. Because of the exacerbation of MG, 
pyridostigmine bromide (60 mg) was administered aily. 
In July 1993, she was admitted to our department because 
of an abnormal shadow on chest X-ray films. Physical 
examinations revealed no palpable lymph nodes in the 
neck, axilla, or inguen. Examination of the eyes showed no 
uveitis. 
Examination of peripheral blood samples showed no 
abnormalities in the leukocyte, erythrocyte, or platelet 
counts but an increase in the CD4/CD 8 ratio among 
lymphocyte subsets. Urinary findings were within normal 
limits. The asparate aminotransferase, alanine amino- 
transferase, alkaline phosphatase, and ~-guanosine triphos- 
From the First Department of Surgery, a First Department of 
Pathology, b Teikyo University School of Medicine, Tokyo, 
Japan. 
J THORaC CARDIOVASC SURG 1995;109:183-4 
Copyright © 1995 by Mosby-Year Book, Inc. 
0022-5223/95 $3.00 + 0 12/8/55535 
phate levels were within normal limits, but the thymol 
turbidity test level was 14.6 U, and the zinc turbidity test 
level was 24.2 U. The total protein concentration was 8.8 
gm/dl with 51.0% c~2-globulin and 29.8% v-globulin. The 
serum level of angiotensin-converting enzyme was 23.4 
U/ml, and the lysozyme level was 14.3 /xg/ml. The eryth- 
rocyte sedimentation rate was 56 mm/hr. The serum levels 
of triiodothyronine, thyroxine, and thrornbin-stimulating 
hormone were within normal imits. Tests for thyroglob- 
ulin and mitochondria antibodies were negative. Rheuma- 
toid factor and antinuclear antibody tests were negative, 
as was the positive protein derivative reaction. 
Chest X-ray examination showed bilateral hilar lymph- 
adenopathy, Chest computed tomographic scanning also 
showed marked bilateral hilar lymphadenopathy but no 
enlargement o f  the thymus or thymoma. Gallium 67 
scintigraphy revealed accumulation-positive images on the 
bilateral hilar areas. A diagnosis of sarcoidosis compli- 
cated by MG (Osserman IIA) was made. 
An operation was performed on October 19, 1993. 
After a T-shaped skin incision and longitudinal sternot- 
omy had been done, the mediastinum was reached and 
extended thymectomy and biopsy of the hilar lymph nodes 
were performed. Histopathologic examination of the hilar 
lymph nodes demonstrated noncaseous granuloma, sup- 
porting the diagnosis of sarcoidosis. 
Four months after the operation, she showed improve- 
ment in symptoms of MG with decreased blepharoptosis 
and diplopia and no fatigability of the skeletal muscles 
without administration of pyridostigmine bromide. Sar- 
coidosis has been observed after the operation without 
treatment, but no substantial changes have occurred in 
serum levels of angioteusin-converting e zyme or lyso- 
zyme. 
MG is an autoimmune disease induced by the appear- 
ance of antiacetylcholine antibody. T cell abnormality is
observed in the peripheral blood, 1 and germinal center 
formation is frequently observed in the thymus tissue. MG 
is closely associated with thymus abnormalities. On the 
other hand, sarcoidosis i a systemic disease characterized 
by formation of epithelioid cell granulomatous lesions not 
accompanied by necrosis, and its pathogenesis is unclear. 
However, recent information has suggested the following 
mechanism of the establishment of epithelioid cell gran- 
ulomatous lesions, although the details are still unknown2: 
(1) T cells are activated after nonspecific stimulation or 
stimulation as an immune response to unknown cause, 
and activated T cells accumulate in the lesion; (2) accu- 
mulated T cells produce lymphokine; (3) lymphokine 
promotes the differentiation of monocytes/macrophages 
to epithelioid cells, resulting in the formation of epithe- 
lioid granuloma. Because the thymus plays an important 
role in the differentiation and growth of T cells, it is 
speculated that MG as "an unknown cause" activates the 
T cell line, inducing the formation of sarcoidosis lesions. 
Some case reports of MG complicated by sarcoidosis 
have been reported. Sarcoidosis developed during the 
remission of MG in some cases 3but during the exacerba- 
tion period in others, 4 showing no consistent tendency. 
Regression of MG and sarcoidosis after thymectomy was 
also reported. 4 In our patient, MG became less severe 
after thymectomy, but sarcoidosis did not. 
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Mediastinal vagal neurilemmoma causing tracheal 
stenosis 
Junya Katoh, MD, Shinpei Yoshii, MD, 
Osamu Suzuki, MD, Shigeru Hosaka,  MD, 
Ryoichi Hashimoto,  MD, and Yusuke Tada, MD, 
Yamanashi, Japan 
Neurogenic tumors of the mediastinum are common 
and constitute the majority of neoplasms of the posterior 
mediastinum. 1 Usually such tumors arise from the inter- 
costal nerve or the sympathetic chain. However, tumors 
originating from the vagus nerve are rare. A review of the 
literature revealed no patient with vagal neurilemmoma 
causing severe tracheal stenosis. We report here a case of 
vagal neurilemmoma in which hemosputum resulted from 
compression of the membranous trachea. 
A 68-year-old man was admitted with a 6-month istory 
of feeling pressure on swallowing and recent onset of 
frequent hemosputum. He had retired from his post as a 
public official 8 years previously, did not smoke, and had 
no history of serious illness. Physical examination showed 
no abnormalities, and results of laboratory findings in- 
cluding urinalysis, complete blood count, blo0d chemistry, 
arterial blood gases, and tumor makers were within nor- 
mal limits. A spirogram also showed no abnormalities. 
Posteroanterior and lateral roentgenograms of the chest 
showed a mass compressing the trachea from behind. A 
computed tomographic scan revealed a well-circum- 
scribed, heterogeneously enhanced mass, which was caus- 
ing tracheal stenosis. Magnetic resonance imaging was 
performed for further anatomic definition of the mass 
(Fig. 1). Examination with a fiberoptic bronchoscope 
disclosed severe extrinsic pressure on the distal trachea 
and mucosal injection (Fig. 2). Transtracheal biopsy was 
impossible because the mucosa had a tendency to bleed. It 
was difficult to establish a definite preoperative diagnosis 
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Fig. 1. Magnetic resonance imaging showing a well-cir- 
cumscribed mass compressing the membranous trachea. 
computed tomography and magnetic resonance imaging 
suggested a benign tumor, such as neurilemmoma or 
neurofibroma, but we could find no case report of benign 
mediastinal tumor associated with frequent hemosputum, 
and a pathologic diagnosis could not be obtained because 
of bleeding from the tracheal mucosa. 
With the preoperative diagnosis of mediastinal neuro- 
genic tumor, which was most likely a neurilemmoma but 
possibly a malignant tumor, a right thoracotomy incision 
was made. A smooth, encapsulated tumor with the dimen- 
sions of 4 × 4 × 3 cm was encountered behind the 
trachea, and careful observation revealed that it was 
originating from the right vagus nerve. Inasmuch as 
examination of frozen sections of the mass showed that 
the tumor was a neurilemmoma originating from the 
vagus nerve, we decided to resect he tumor completely. 
Because the tumor could not be dissected from the nerve, 
the tumor was extirpated with proximal and distal igation 
and division of the vagus nerve. At that time, a 2 cm defect 
in the membranous trachea of the carina occurred, and a 
double-lumen endobronchial tube was placed into the left 
